Cost-effectiveness of omalizumab for the treatment of inadequately controlled severe allergic asthma in Chinese children.
Saved in:
| Title: | Cost-effectiveness of omalizumab for the treatment of inadequately controlled severe allergic asthma in Chinese children. |
|---|---|
| Authors: | Zhou H; Department of VIP, Shanghai Children's Hospital, affiliated with the School of Medicine, Shanghai Jiaotong University, Shanghai, China., Lu Y; Department of Pediatrics, Ren Ji Hospital, South Campus, School of Medicine, Shanghai Jiaotong University, Shanghai, China., Wu B; Medical decision and Economic Group, Department of Pharmacy, Ren Ji Hospital, South Campus, School of Medicine, Shanghai Jiaotong University, Shanghai, China., Che D; Department of VIP, Shanghai Children's Hospital, affiliated with the School of Medicine, Shanghai Jiaotong University, Shanghai, China. |
| Source: | The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2020 Jan; Vol. 57 (1), pp. 87-94. Date of Electronic Publication: 2018 Dec 03. |
| Publication Type: | Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8106454 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-4303 (Electronic) Linking ISSN: 02770903 NLM ISO Abbreviation: J Asthma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
